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Abstract
Background—Particulate matter (PM) exposures have been linked with poor respiratory health
outcomes, especially among susceptible populations such as asthmatic children. Smoke from
biomass combustion for residential home heating is an important source of PM in many rural or
peri-urban areas in the United States.
Aim—To assess the efficacy of residential interventions that reduce indoor PM exposure from
wood stoves and to quantify the corresponding improvements in quality of life and health
outcomes for asthmatic children.
Design—The Asthma Randomized Trial of Indoor wood Smoke (ARTIS) study is an in-home
intervention study of susceptible children exposed to biomass combustion smoke. Children, ages 7
to 17, with persistent asthma and living in homes that heat with wood stoves were recruited for
this three arm randomized placebo-controlled trial. Two household-level intervention strategies,
wood stove replacement and air filters, were compared to a sham air filter placebo. Improvement
in quality of life of asthmatic children was the primary outcomes. Secondary asthma-related health
outcomes included peak expiratory flow (PEF) and forced expiratory volume in first second
(FEV1), biomarkers in exhaled breath condensate, and frequency of asthma symptoms, medication
usage, and healthcare utilization. Exposure outcomes included indoor and outdoor PM2.5 mass,
particle counts of several size fractions, and carbon monoxide.
Discussion—To our knowledge, this was the first randomized trial in the US to utilize
interventions targeting residential wood stoves to assess the impact on indoor PM and health
outcomes in a susceptible population.
Trial registration—ClincialTrials.gov NCT00807183.
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1. Introduction
Mortality and morbidity studies have demonstrated that PM is associated with adverse
effects on respiratory health, particularly among susceptible populations such as asthmatics.
Follow-up of cohorts or panels of asthmatic patients have demonstrated that increases in
levels of PM10 and PM2.5 (PM less than 10 and 2.5 μm in aerodynamic diameter,
respectively) are associated with increases in severe asthma attacks, asthma symptoms,
asthma medication usage, and hospital emergency department visits for asthma and upper
respiratory infections [1–14]. PM exposures have been shown to result in annual lung
function growth deficits that are greater than that attributed to passive smoke exposure in
children [15].
Biomass combustion from residential heating devices can be a large contributor to ambient
PM in rural communities. The Consumer Product Safety Commission estimates that there
are 8.9 million wood stoves currently in use in the US [16]. The majority of these are old
and inefficient, resulting in high levels of PM emissions [17]. In semi-urban to very rural
environments, estimates of the wood smoke contribution to ambient particulate levels can
range from 10% to 90% [18–20]. Wood stoves can also be significant sources of PM2.5 to
the indoor environment. From an exposure and health point of view, this is important, as
most people spend the majority of their time indoors, as much as 95% in some areas [21,
22].
Health agencies and clinical practitioners are increasingly interested in identifying cost-
effective interventions to improve quality of life among asthmatic children. In addition to
improved clinical management, approaches may include strategies that reduce inhalation
exposures to known asthma exacerbation triggers. Several studies have tested single [23–29]
or multiple [30–33] home-based interventions to improve childhood asthma morbidity. To
date all such randomized controlled trials in the United States have taken place in urban
settings, and none of these studies specifically addressed in-home wood smoke-derived PM
exposures. More recently, intervention trials in developing country settings have targeted
indoor exposures due to biomass combustion cook stoves [34, 35]. However, the settings
and exposure scenarios in developing countries are distinct from that of wood stove
exposures in the United States or other developed countries. In addition, these cook stove
intervention trials have focused on corresponding improvements in frequency of child
respiratory infections rather than reductions in asthma morbidity.
In this paper, we present the project methodologies of the first randomized controlled trial to
evaluate interventions targeting biomass smoke PM from older model (non-EPA certified,
manufactured < 1995) residential wood stoves in homes of asthmatic children. This study
took place in semi-urban to very rural areas of Montana, Idaho, and Alaska where residential
wood combustion is the major source of PM2.5 and the primary source of home heating
throughout the winter months.
2. Methods
2.1 Study overview
This was a three-arm randomized placebo-controlled intervention trial with two treatment
arms, allowing for the assessment of both high and low cost strategies for reducing in-home
wood smoke PM relative to a placebo. The intervention trial was targeted at asthmatic
children living in non tobacco smoking homes that used older model wood stoves as the
primary source of heating. Subjects were recruited as described below and randomized to
one of three treatments: the placebo group receiving air filtration devices with a non-
functioning filter (Tx1), the wood stove intervention group receiving newer, cleaner burning
Noonan and Ward Page 2
EPA-certified wood stoves (Tx2), and the air filter group receiving functioning air filtration
devices (Tx3).
The exposure and health outcomes observations took place in each household on two
occasions during each of the pre- and post-intervention winter periods. The four exposure
sampling episodes included 48-hour continuous measurements of PM2.5 mass both inside
and outside the homes. Other indoor measures included particle counts for several PM size
fractions, carbon monoxide, temperature, and relative humidity. A one-week retrospective
quality of life instrument, assessed twice during each winter period, was used as the primary
health outcome variable. Self-collected pulmonary function measures were recorded twice
daily for two, two-week periods each winter. Parents reported on asthma symptoms and
asthma medication usage. During each 48-hour exposure sampling period at a given home,
children collected exhaled breath condensate and spot urine samples on two consecutive
mornings (Figure).
2.2 Study locations
The research proposed in this study was conducted in the northern Rocky Mountains
(Montana and Idaho) and Alaska, where wood stove usage for residential home heating is
prevalent. Specifically, intervention based studies were conducted in the following regions:
1) a 200-mile radius surrounding Missoula in western Montana; 2) the Nez Perce Indian
Reservation in Idaho; and 3) Fairbanks, Alaska. These locations were chosen due to the
existing local capabilities and established partnerships.
2.3 Subject selection and eligibility criteria
Our target sample size was 108 asthmatic children. We identified eligible asthmatic children
and households through both active and passive procedures. Active recruitment was initiated
through the administration of a brief student-based asthma and respiratory survey to 5th
through 11th grade students. The survey, based on the International Study of Asthma and
Allergy in Children (ISAAC) questionnaire, was validated for this age group [36]. A
question on whether or not the child’s residence contained a wood stove used for heating
was included in the survey. Based on the results of these surveys, we generated a list of
potentially eligible subjects reporting asthma symptoms and wood stove usage. Passive
recruitment occurred when parents contacted personnel after learning about the study
through posted flyers or notifications distributed through the schools.
The second step of the subject identification process was a telephone interview of a parent at
potentially eligible households. Parents were asked to confirm whether or not their child
currently had physician-diagnosed asthma. Parents also reported the approximate age of
their wood stove and whether or not their wood stove was their primary source of heating.
We also confirmed with the parent that there were no tobacco smokers in the household. If
the child and the corresponding home was still eligible at this point we asked the parent
several questions regarding the child’s frequency of daytime symptoms, nighttime
symptoms, and activity-limiting asthma exacerbations. Based on this initial assessment,
eligible subjects included children, age 7 to 17 years, with mild to severe persistent asthma
residing in a non tobacco smoking household that used an older model wood stoves as their
primary source of heating. Upon completion of baseline measures during the pre-
intervention winter, subjects were randomized into one of three treatment arms.
2.4 Interventions
Placebo Treatment, Inactive Air Filtration Units (Tx1)—Within each randomly
assigned placebo home, two individual air filtration units with placebo filter material were
utilized. A large (20′ × 18′) Filtrete air filtration unit (Ultra Clean Air Purifiers, 3M, St.
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Paul, MN) with placebo filter was placed in the same room as the woodstove. Within the
child’s bedroom, a smaller Filtrete (17′ × 10′) unit with placebo filter was installed. Both
units were operated on the “high” setting throughout the duration of the winter, with filters
changed out monthly. To assess compliance with continuous usage, each Filtrete unit was
fitted with a data logging (voltage measuring) device which monitored on/off status. Upon
completion of the study, placebo-assigned homes were provided with the appropriate filters
to restore the air cleaning functionality of the unit.
Wood Stove Changeout Treatment (Tx2)—Older model wood stoves were changed
out and replaced with EPA-certified wood stoves. Note that alternatives such as pellet,
natural gas, propane, etc. stoves were not provided as a changeout. The new stoves were all
certified as low-emission according to EPA standards (produces only 2 to 5 grams of smoke
per hour), and labeled by the Underwriters’ Laboratories of Canada (ULC) or another testing
and certification body for safety. EPA-certified wood stoves were purchased and installed by
certified technicians within each community. In some cases, new hearth pads and venting
packages were provided to the residences to meet code. Following installation, a contracted
wood stove expert conducted specific training on best burn practices within the home, and
verified the successful installation of the new stoves.
Air Filtration Unit Treatment (Tx3)—Filtrete Ultra Clean Air Purifiers (3M, St. Paul,
MN) with active filters were utilized in the Tx3 arm. These devices have previously been
shown to reduce indoor PM in wood stove homes [37]. Like Tx1, households randomized to
the active filtration unit intervention were provided with two units – a larger one (20′ × 18′)
for the same room as the wood stove and a smaller one (17′ × 10′) for the child’s bedroom.
Filters were changed out approximately once per month in an effort to maximize collection
efficiency. Measures to assess and ensure compliance with continuous usage of the units
were the same as described above for Tx1.
2.5 Health outcomes
The Pediatric Asthma Quality of Life Questionnaire (PAQLQ) is a 23-item asthma-specific
battery which provides domain scores for symptoms (10 items), activity limitation (5 items),
and emotional function (8 items) [38]. The score for each domain is the average of the items
within it, with scores ranging from one to seven (with seven as the optimal score). Symptom
and activity limitation subscales were reverse-scored. The total PAQLQ score was
calculated as the mean score across the three domains. This questionnaire was directly
administered to children twice per winter period.
Using the PiKo-1 meter (Ferraris), children performed a peak flow test two times daily (in
the morning and in the evening) for a two week period following each 48-hour exposure
sampling episode. The subject with parent supervision was trained to place the mouthpiece
in their mouth and blow as hard as they could for several seconds. The child repeated this
three times for each test, and the device stored the best result for both peak expiratory flow
(PEF) and exhaled volume in the first second (FEV1). Outcomes from these measures
included average morning PEF and FEV1, average evening PEF and FEV1, and PEF
evening to morning variability. During the same two-week period, parents of participating
children were asked to record health-related events for their child, including asthma
symptoms during the day, night, and/or during exercise. The parent also reported on the
child’s acute usage of systemic corticosteroids and health care utilization, including
unscheduled outpatient visits, emergency department visits, or hospitalizations. The two-
week peak flow measures and parent reporting of symptoms, medication usage and
healthcare utilization was repeated twice during each winter period directly following the
48-hour exposure sampling events.
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2.6 Biomarker Analysis
Four exhaled breath condensate (EBC) samples per winter were collected using an Rtube
breath condensate collector (Respiratory Research Inc., Charlottesville, VA). This device
consists of a pre-cooled aluminum sleeve placed over the outside of a disposable vertical
condensation/collection tube and connected to two-way non-rebreathing valve and
mouthpiece. Subjects were instructed to breathe into the mouthpiece for 10–15 minutes on
each morning of the two, 48-hour exposure sampling episodes per winter. EBC samples
were aliquoted, stored in the field freezers, transported on dry ice to the laboratory, and
stored at −80°C for future analyses. Samples were analyzed for pH and 8-isoprostane, a
marker of oxidative stress. Concentrations of 8-isoprostane were measured by specific
enzyme immunoassay kits (Cayman Chemical, Ann Arbor, MI) [39, 40].
On the same schedule as EBC collection, children collected spot urine samples. Although an
eligibility requirement was for subjects to live in non-smoking households, we analyzed
subjects’ urine samples for cotinine to characterize exposure to environmental tobacco
smoke using a cotinine ELISA kit (CalBioTech, Spring Valley, CA). To account for urine
dilution, urine samples were also analyzed for creatinine by ELISA (Cayman Chemical
Company, Ann Arbor, MI). Standards and samples were analyzed in duplicate.
2.7 Exposure assessment
During each 48-hour sampling event per each of two winters, three air samplers were
deployed within the home: 1) a DustTrak 8530 (TSI, Shoreview, MN) that continuously
measured PM2.5 mass, 2) a Lighthouse 3016-IAQ particle counter (Lighthouse Worldwide
Solutions, Fremont, CA) that continuously measured particle counts within five distinct size
fractions (0.3 – 10 μm size range), and 3) a Q-Trak (TSI, Shoreview, MN) that continuously
measured carbon monoxide, carbon dioxide, temperature and relative humidity. While
sampling, these monitors were co-located and placed approximately 3–5 feet off of the
ground within the same room as the wood stove. A second DustTrak (Model 8520 or 8530)
was located outside the home within an enclosure, measuring ambient PM2.5 mass during
the periods of interest. All samplers had 60-second recording intervals, and were zero
calibrated prior to each sampling event. It is possible that the participant homes are located
in proximity to other homes with wood stoves, and such sources of nearby PM could impact
local exposures among participants. The co-localization of continuous ambient and indoor
PM2.5 monitors at each participant residence will allow for a characterization of home
infiltration rate and the distinction of indoor- versus outdoor-generated PM per previously
published methods.[41, 42] These source calculations and infiltration rates will also be
important in further describing exposure reduction effectiveness of the two strategies with
one treatment arm (stoves) targeting the lower emissions from in-home wood burning and
the other treatment arm (air filters) targeting indoor PM regardless of source.
Descriptive home characteristics data were captured from each residence, including size and
age of home, presence of pets and secondary sources of heating. To complement the
exposure sampling approach, a home activity record was used to identify any activities that
may have generated elevated PM2.5 levels during each sampling event (cooking, cleaning,
etc). A wood burn record was also used to determine frequency of wood burning, and dates/
times that the wood stove was loaded and stoked during each sampling event. Finally, a
child in-home record was used to document the times the subject was actually within the
home during the period of exposure assessment.
2.8 Other measures
Several additional measures were collected from children or their respective homes on only
one occasion. Spirometry measures were collected from subjects using the EasyOne
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Frontline portable spirometer (ndd, Andover, MA) with disposable spirette breathing tubes.
Subjects were asked to perform a forced vital capacity (FVC) maneuver, and two good
maneuvers were required for a valid test. Spirometry outcomes included FEV1 percent of
predicted (%), FVC% and FEV1/FVC%. Subject sensitivity to selected indoor allergens was
assessed using a skin prick test (Multi Test II, Lincoln Diagnostics, Decatur, IL). Allergens
tested included dust mite, dog, cat, cockroach, aspergillis and alternaria (ALK Abello,
Round Rock, TX). Dust samples were collected in the homes at one time point to assess
indoor allergen levels in settled dust using a Dustream collector system (Indoor
Biotechnologies, Charlottesville, VA). Home visits for these measures were arranged by
convenience and were not coordinated to correspond to the above-mentioned health on
exposure assessment sampling visits. Archived meteorological data were also collected for
the exposure sampling days at given homes from the nearest weather station.
2.9 Planned analysis
Statistical analyses will be conducted using SAS v9.2 (Cary, NC). Analyses will be
performed according to intention to treat to include subjects that were randomized to
treatment and have at least one baseline measure. The primary independent variable will be
assignment to treatment arm. A descriptive analysis (e.g., frequencies, percents, and means)
will be conducted to describe the groups with relation to the primary dependent variables
and other pertinent demographic variables at baseline. T-tests, or χ2 tests as appropriate,
will be used to compare differences between groups in descriptive characteristics such as
age, number of other children in the home, sex, race/ethnicity, household income, allergen
sensitivity, allergen levels in dust samples, medication use, and asthma severity.
The primary dependent variable for this trial is change in PAQLQ scores from pre-
intervention winter to post-intervention winter. The two PAQLQ scores will be averaged
within each winter period for each subject. The first crude analysis will utilize t-tests to
assess differences (Tx2 versus Tx1 and Tx3 versus Tx1) in total PAQLQ scores change, as
well as change in the three subscale scores for PAQLQ. We will use linear mixed models
with fixed effects for treatment group, random effects for repeated measures within subject
and adjustment for across group baseline differences that may occur despite the
randomization strategy. Because the analysis requires combining data that were collected in
different communities over different time periods, we will also include community or cohort
year as a factor in the linear mixed models. It is also possible that particular differences
across community may be evident for only one of the three communities. Examples of such
factors could be difference in ambient winter temperature between pre-intervention and
post-intervention winters or difference in race/ethnicity composition. If so, these factors will
be included in the models to determine if there are differential effects on change in PAQLQ
scores according to these factors. Because we will be using intention to treat in our primary
analysis, we will maintain subjects in the analysis when their urinary cotinine suggests
passive or active exposure to tobacco smoke. Secondary analyses after excluding these
subjects may be conducted if positive cotinine is an important variable in the multiple
variable analyses. Other factors to be considered in secondary analyses will include baseline
asthma severity, medication use and sensitivity to indoor allergens as potential effect
modifiers.
The above-described exposure variables will also be used in an exposure response analysis
of PAQLQ and other health outcomes. We will use linear mixed models to assess whether
reductions in indoor PM2.5 or particle counts are associated with the asthma-related
outcomes and biomarkers. Each exposure variable will be considered separately because
changes in these measures will be highly collinear.
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2.10 Expected results and power calculations
Each treatment arm will be assessed for change in PAQLQ score from the pre-intervention
winter period to the post-intervention winter period. When comparing two groups (e.g., Tx1
versus Tx2), a sample size of 30 subjects per group will provide 80% power to demonstrate
a difference in scores of 1.00 units or greater at the 95% confidence level. This estimate was
based on an independent t-test assuming a common standard deviation of 1.36 which was
the baseline standard deviation of baseline PAQLQ measures in a prospective childhood
asthma intervention study that, like our study, combined three different communities [43].
When evaluating within group changes, a sample size of 30 subjects per group would
provide 80% power to demonstrate a difference in pre- versus post-intervention PAQLQ
scores of 0.72 units. These estimates of inter-group and intra-group detectable differences
are reasonable as a longitudinal study of indoor environmental interventions among
asthmatic children in three communities demonstrated improvement of 1.32 units at 13
months of follow-up [33, 43]. For symptom reporting we will evaluate changes between pre-
and post-intervention in days with asthma symptoms in a two week reporting period. We
assumed a standard deviation of 2.52 based on a large-scale home intervention study
evaluating the same outcome [30]. Our sample size of 30 subjects per intervention group
would provide 80% power to detect a within-group change of 1.33 symptom days in a two
week reporting period assuming a paired t-test with a 95% confidence interval. By
comparison, home-based intervention studies among asthmatic children have yielded
reductions in two-week symptom days ranging from 2.6 to 4.8 days in the intervention
groups [30, 31]. For change in PEF variability (%), we assumed a standard deviation of
16.74 based on a previous intervention trial of asthmatic children [30]. Our sample size of
30 subjects per intervention group would provide 80% power to detect a between-group
difference of 8.9% PEF variability.
3. Discussion
Our study is currently evaluating the reduction in indoor PM following the described
interventions and the corresponding impact on asthmatic children. These observations
combined with a carefully designed exposure and health outcome assessment will allow us
to characterize the wood smoke effects on respiratory health of children, and to evaluate
clinically meaningful health improvements among asthmatic children. The use of the
randomized trial design is atypical for environmental exposure research. Clearly, assigning
subjects to a particular environmental agent suspected to cause adverse health consequences
would be unethical. The study presented here describes a unique opportunity to evaluate
environmental exposure-response relationships in wood stove homes using the randomized
trial design. The intervention treatment is aimed at the household to reduce subject in-home
exposures to PM. Other similar intervention studies have been conducted [23–35], but these
have not specifically focused on wood stove interventions in homes with asthmatic children.
Importantly, our approach tested two distinct intervention strategies. The first strategy, the
wood stove intervention arm, exclusively targeted wood combustion-derived PM. We have
demonstrated previously that improved combustion efficiencies from new wood stoves can
result in lower emissions [44–46]. Although our exposure assessment strategy was limited to
particle phase contaminants, we anticipated that the wood stove intervention will also result
in changes to gas phase emissions as noted in our prior studies [47, 48]. It is possible that
exposure reductions in these wood stove intervention homes will be less than anticipated due
to indoor infiltration of outdoor PM from other nearby sources or due to improper stove
operation by the resident.
The second strategy, the air filter intervention arm, targeted indoor PM regardless of source.
A key advantage of this intervention was that residents in this arm were blinded to
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intervention status with respect to the placebo arm (i.e., sham air filter). Comparing
outcomes in the air filter versus the placebo group may be particularly important with
respect to our subjective quality of life measures. Such reporting bias could be present in our
wood stove intervention arm but will be minimized in our air filter versus placebo
comparisons. One limitation of the air filter arm, however, is that other allergens (i.e. pollen
and animal dander) may be reduced within the home in conjunction with wood smoke PM.
These factors could potentially complicate the interpretation of our findings related to
reduced asthma symptoms and reduced wood smoke concentrations within the residences.
Relatively few studies have been conducted in the United States to assess the health impacts
of wood smoke from residential wood stove usage. Cross-sectional observational studies in
the United States indicated higher frequency of symptoms that can be loosely described as
asthma-related [49–51] and lung function decrement [52] among children living in wood
stove homes compared to children living in homes without wood stoves. An ecological
study examined respiratory symptoms in a wood stove community compared to a non-wood
stove community [53]. Although there were no differences overall, there was a higher
frequency of wheezing among children under five years old in the wood stove community,
suggesting that young children may be susceptible to the adverse respiratory effects of wood
smoke [53]. Studies of children living on the Navajo reservation in Arizona demonstrated
greater risk of acute lower respiratory illness among children from households with wood
stoves [54, 55]. Two ecologic studies in areas where residential wood smoke accounted for
42% and 34% of PM showed associations between PM levels and hospital visits for asthma
[11, 14]. A recent ecological study was also conducted in a community that more closely
approximates the exposure profile for northern Rocky Mountain wood smoke-impacted
communities. In Christchurch, New Zealand approximately 90% of PM was emitted from
wood burners and open fires during winter. These investigators observed a greater than
three-fold risk in total respiratory hospital admissions associated with PM [56]. More
recently, a community-wide wood stove replacement program resulted in substantial
reductions in ambient wintertime PM2.5 (27%) and corresponding reductions in the
frequency of reported wheeze and respiratory infections among children [57, 58].
The epidemiological research described above has largely focused on ambient measures of
wood smoke-derived PM and its association with respiratory effects. It is well understood
that indoor exposures to pollutants and allergens are important determinants of asthma
morbidity. Randomized trials of pharmacological treatment and case management strategies
for mitigation of asthma morbidity are numerous, but in recent years many studies have also
investigated the efficacy of home-based interventions to reduce important residential
exposures among asthmatic children. The majority of studies have investigated a variety of
interventions aimed at reducing allergen exposures in the home. Single intervention studies
which have evaluated health outcomes resulting from strategies to mitigate dust mite,
cockroach, mold, or pet allergen exposures have demonstrated positive, although not
universal, benefits [23–29]. A multi–center randomized controlled trial of over 900 inner-
city asthmatic children with positive skin allergy tests assessed a high intensity multifaceted
intervention which included education and environmental programs specific to the patient’s
allergy profile [30]. The intervention group in this study demonstrated reductions in asthma
symptoms, asthma-related emergency health care visits, and school absences [30]. A smaller
randomized controlled trial of inner-city children with a similar high intensity education and
environmental intervention demonstrated reductions in asthma-related urgent health care
visits and improvements in caregiver quality of life [31]. A third randomized controlled trial
targeting inner-city asthmatic children found a significant improvement in daytime
symptoms among children in homes receiving a multifaceted intervention targeting allergen
and PM reduction [32]. Finally, a longitudinal study reporting pre- versus post-intervention
measures demonstrated the effectiveness of a multifaceted intervention which included
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integrated pest management and education and support for asthma case management,
yielding significant reductions in asthma symptoms and improvements in quality of life
among the treated group [33, 43].
With few exceptions, the studies cited above, including the multifaceted interventions, do
not directly target or assess in-home PM exposures. The multifaceted interventions included
environmental tobacco smoke as a component to be addressed through a combination of
education, behavioral alteration strategies, and environmental controls. Two randomized
controlled trials have reported on the effectiveness of air filtration units in reducing in-home
PM [32, 59]. A small study reported a 73% reduction in total suspended particulates due to
air filter usage and found modest improvements in total symptoms among the air filtration
treatment group [59]. This trial contributed to a 2002 meta-analysis of air filtration unit
studies which found significant improvements in total symptoms and sleep disturbance
among asthmatics in homes in the air filtration treatment arm [29]. A second, more recent
randomized controlled trial reporting on PM levels demonstrated a 39% reduction in PM10
among homes using air filtration units [32]. As described previously, this study found
overall reductions in symptom reporting among the treatment group, but the multifaceted
intervention which included behavioral and allergen-targeted environmental interventions
makes it difficult to determine the main effect of PM reduction among this treatment group.
Importantly, none of these intervention studies targeted homes at risk for non-tobacco
related PM exposure such as homes using wood stoves as their primary heating source.
Conclusion
In many rural communities located in cold weather climates, use of a wood stove for
residential home heating is common. Residential wood smoke is an important source of
indoor PM, and this study has the potential to yield important information regarding the
health of asthmatic children living in homes containing wood stoves and strategies for
effective exposure reductions strategies. Intriguing parallels can be drawn between this
study and current global efforts to reduce indoor biomass combustion exposures among
children in developing countries [34, 35, 60]. In both developed and developing country
settings, the introduction of improved stove technologies alone may not yield sufficient or
consistent reductions in indoor biomass smoke exposures [34, 44–46]. A greater
understanding of the behavioral, social, economic and technological aspects of these
interventions may help to optimize exposure reductions and health improvements. In
summary, this intervention trial will provide substantial power to assess health outcomes
changes resulting from reductions in wood smoke exposures among asthmatic children, a
population that is vulnerable to PM-related health effects. We will be able to evaluate
clinically relevant outcomes of the planned intervention and ultimately to assess the efficacy
of incorporating this intervention into future multifaceted public health strategies for
susceptible children.
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Figure 1.
Data collection strategy. Four sampling episodes occur at each participant home. Two
sampling episodes occur during the pre-intervention winter, and two sampling episodes
occur during the post-intervention winter. The implementation of household interventions
(i.e., air filter, new wood stove, or placebo filter) occurs during the summer or fall between
the two winters. Each sampling episode, illustrated in the table surrounded by the dashed
line box, includes data collection for both health outcomes and exposure assessment. The
dashed arrow for the pediatric asthma quality of life survey indicates that the data reflect the
child’s symptoms, limitations and other quality of life indicators during the week prior to the
corresponding home visit. Solid lines indicate periods during which data are collected on a
continuous basis. Solid dots indicate measures that are assessed at specific time points (e.g.,
mornings for biological sample collections or mornings and evenings for pulmonary
function measures).
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